| Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100 B Nervi, P Ramirez, MP Rettig, GL Uy, MS Holt, JK Ritchey, JL Prior, ... Blood, The Journal of the American Society of Hematology 113 (24), 6206-6214, 2009 | 581 | 2009 |
| Biliary tract cancer JW Valle, RK Kelley, B Nervi, DY Oh, AX Zhu The Lancet 397 (10272), 428-444, 2021 | 576 | 2021 |
| Cytokines and hematopoietic stem cell mobilization B Nervi, DC Link, JF DiPersio Journal of cellular biochemistry 99 (3), 690-705, 2006 | 346 | 2006 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 259 | 2023 |
| Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy I Riquelme, K Saavedra, JA Espinoza, H Weber, P García, B Nervi, ... Oncotarget 6 (28), 24750, 2015 | 157 | 2015 |
| AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent AF Cashen, B Nervi, J DiPersio Future oncology 3 (1), 19-27, 2007 | 118 | 2007 |
| Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID β2mnull mice B Nervi, MP Rettig, JK Ritchey, HL Wang, G Bauer, J Walker, ... Experimental hematology 35 (12), 1823-1838, 2007 | 88 | 2007 |
| Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis ZJ Ward, M Walbaum, B Walbaum, MJ Guzman, JJ de la Jara, B Nervi, ... The Lancet Oncology 22 (10), 1427-1437, 2021 | 83 | 2021 |
| Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial ME Balcells, L Rojas, N Le Corre, C Martínez-Valdebenito, ME Ceballos, ... PLoS medicine 18 (3), e1003415, 2021 | 80 | 2021 |
| Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up F Salech, S Valderrama, B Nervi, JC Rodriguez, D Oksenberg, A Koch, ... Annals of hepatology 10 (1), 99-102, 2016 | 80 | 2016 |
| Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy C Bizama, P García, JA Espinoza, H Weber, P Leal, B Nervi, JC Roa Cancer Treatment Reviews 41 (3), 222-234, 2015 | 72 | 2015 |
| Tratamiento y prevención de la mucositis oral asociada al tratamiento del cáncer G Ruiz-Esquide, B Nervi, A Vargas, A Maíz Revista médica de Chile 139 (3), 373-381, 2011 | 56 | 2011 |
| The CCL2/CCR2 axis affects transmigration and proliferation but not resistance to chemotherapy of acute myeloid leukemia cells P Macanas-Pirard, T Quezada, L Navarrete, R Broekhuizen, A Leisewitz, ... PloS one 12 (1), e0168888, 2017 | 50 | 2017 |
| Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates … P Macanas-Pirard, R Broekhuizen, A González, C Oyanadel, D Ernst, ... Oncotarget 8 (14), 23073, 2017 | 45 | 2017 |
| A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy J Jimenez de la Jara, G Bastias, C Ferreccio, C Moscoso, S Sagues, ... Biological research 48, 1-15, 2015 | 42 | 2015 |
| Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis P Macanas-Pirard, A Leisewitz, R Broekhuizen, K Cautivo, FM Barriga, ... PLoS One 7 (5), e37203, 2012 | 42 | 2012 |
| The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses C Durán-Aniotz, G Segal, L Salazar, C Pereda, C Falcón, F Tempio, ... Cancer Immunology, Immunotherapy 62, 761-772, 2013 | 33 | 2013 |
| CXCR4 and mobilization of hematopoietic precursors MP Rettig, P Ramirez, B Nervi, JF DiPersio Methods in enzymology 460, 57-90, 2009 | 33 | 2009 |
| Enfermedad fúngica invasora en pacientes hemato-oncológicos y receptores de trasplante de precursores hematopoyéticos bajo la perspectiva de los criterios diagnósticos EORTC/MSG R Rabagliati, G Fuentes, AM Guzmán, E Orellana, J Oporto, I Aedo, ... Revista chilena de infectología 26 (3), 212-219, 2009 | 30 | 2009 |
| Treatment and prevention of cancer treatment related oral mucositis G Ruiz-Esquide, B Nervi, A Vargas, A Maiz Revista medica de Chile 139 (3), 373-381, 2011 | 28 | 2011 |
